RankingsPricing
  1. US-listed companies
  2. ABEONA THERAPEUTICS INC.
  3. Financials
  4. EBITDA margin (%)

ABEONA THERAPEUTICS INC.ABEO

Market cap
$251.69M
P/E ratio
SummaryFinancials
Period EndEBITDA margin (%) YoY (%)
Dec 31, 2023-1,281.3-62.11%
Dec 31, 2022-3,382+17.18%
Dec 31, 2021-2,886.2+275.64%
Dec 31, 2020-768.3-58.72%
Dec 31, 2018-1,861.4-42.50%
Dec 31, 2017-3,237.2+24.82%
Dec 31, 2016-2,593.5+49.89%
Dec 31, 2015-1,730.3+412.99%
Dec 31, 2014-337.3+81.21%
Dec 31, 2013-186.1+110.36%
Dec 31, 2012-88.5-78.60%
Dec 31, 2011-413.6

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)